Anion transport by the human sodium-iodide symporter (hNIS) is an established target for molecular imaging and radionuclide therapy. Current radiotracers for PET of hNIS expression are limited to 124I- and 18F-BF4- We sought new 18F-labeled hNIS substrates offering higher specific activity, higher affinity, and simpler radiochemical synthesis than 18F-BF4- METHODS: The ability of a range of anions, some containing fluorine, to block 99mTcO4- uptake in hNIS-expressing cells was measured. SO3F- emerged as a promising candidate. 18F-SO3F- was synthesized by reaction of 18F- with SO3-pyridine complex in MeCN and purified using alumina and quaternary methyl ammonium solid-phase extraction cartridges. Chemical and radiochemical purity and serum stability were determined by radiochromatography. Radiotracer uptake and efflux in hNIS-transduced HCT116-C19 cells and the hNIS-negative parent cell line were evaluated in vitro in the presence and absence of a known competitive inhibitor (NaClO4). PET/CT imaging and ex vivo biodistribution measurement were conducted on BALB/c mice, with and without NaClO4 inhibition. RESULTS: Fluorosulfate was identified as a potent inhibitor of 99mTcO4- uptake via hNIS in vitro (half-maximal inhibitory concentration, 0.55-0.56 μM (in comparison with 0.29-4.5 μM for BF4-, 0.07 μM for TcO4-, and 2.7-4.7 μM for I-). Radiolabeling to produce 18F-SO3F- was simple and afforded high radiochemical purity suitable for biologic evaluation (radiochemical purity > 95%, decay-corrected radiochemical yield = 31.6%, specific activity ≥ 48.5 GBq/μmol). Specific, blockable hNIS-mediated uptake in HCT116-C19 cells was observed in vitro, and PET/CT imaging of normal mice showed uptake in thyroid, salivary glands (percentage injected dose/g at 30 min, 563 ± 140 and 32 ± 9, respectively), and stomach (percentage injected dose/g at 90 min, 68 ± 21). CONCLUSION: Fluorosulfate is a high-affinity hNIS substrate. 18F-SO3F- is easily synthesized in high yield and very high specific activity and is a promising candidate for preclinical and clinical PET imaging of hNIS expression and thyroid-related disease; it is the first example of in vivo PET imaging with a tracer containing an S-18F bond.
Anion transport by the human sodium-iodide symporter (hNIS) is an established target for molecular imaging and radionuclide therapy. Current radiotracers for PET of hNIS expression are limited to 124I- and 18F-BF4- We sought new 18F-labeled hNIS substrates offering higher specific activity, higher affinity, and simpler radiochemical synthesis than 18F-BF4- METHODS: The ability of a range of anions, some containing fluorine, to block 99mTcO4- uptake in hNIS-expressing cells was measured. SO3F- emerged as a promising candidate. 18F-SO3F- was synthesized by reaction of 18F- with SO3-pyridine complex in MeCN and purified using alumina and quaternary methyl ammonium solid-phase extraction cartridges. Chemical and radiochemical purity and serum stability were determined by radiochromatography. Radiotracer uptake and efflux in hNIS-transduced HCT116-C19 cells and the hNIS-negative parent cell line were evaluated in vitro in the presence and absence of a known competitive inhibitor (NaClO4). PET/CT imaging and ex vivo biodistribution measurement were conducted on BALB/c mice, with and without NaClO4 inhibition. RESULTS: Fluorosulfate was identified as a potent inhibitor of 99mTcO4- uptake via hNIS in vitro (half-maximal inhibitory concentration, 0.55-0.56 μM (in comparison with 0.29-4.5 μM for BF4-, 0.07 μM for TcO4-, and 2.7-4.7 μM for I-). Radiolabeling to produce 18F-SO3F- was simple and afforded high radiochemical purity suitable for biologic evaluation (radiochemical purity > 95%, decay-corrected radiochemical yield = 31.6%, specific activity ≥ 48.5 GBq/μmol). Specific, blockable hNIS-mediated uptake in HCT116-C19 cells was observed in vitro, and PET/CT imaging of normal mice showed uptake in thyroid, salivary glands (percentage injected dose/g at 30 min, 563 ± 140 and 32 ± 9, respectively), and stomach (percentage injected dose/g at 90 min, 68 ± 21). CONCLUSION: Fluorosulfate is a high-affinity hNIS substrate. 18F-SO3F- is easily synthesized in high yield and very high specific activity and is a promising candidate for preclinical and clinical PET imaging of hNIS expression and thyroid-related disease; it is the first example of in vivo PET imaging with a tracer containing an S-18F bond.
Authors: James A H Inkster; Kate Liu; Samia Ait-Mohand; Paul Schaffer; Brigitte Guérin; Thomas J Ruth; Tim Storr Journal: Chemistry Date: 2012-07-17 Impact factor: 5.236
Authors: Amanda J Weeks; Maite Jauregui-Osoro; Marcel Cleij; Julia E Blower; James R Ballinger; Philip J Blower Journal: Nucl Med Commun Date: 2011-02 Impact factor: 1.690
Authors: Maite Jauregui-Osoro; Kavitha Sunassee; Amanda J Weeks; David J Berry; Rowena L Paul; Marcel Cleij; Jasvinder Paul Banga; Michael J O'Doherty; Paul K Marsden; Susan E M Clarke; James R Ballinger; Istvan Szanda; Sheue-Yann Cheng; Philip J Blower Journal: Eur J Nucl Med Mol Imaging Date: 2010-06-25 Impact factor: 9.236
Authors: Tom Haywood; Corinne Beinat; Gayatri Gowrishankar; Chirag B Patel; Israt S Alam; Surya Murty; Sanjiv Sam Gambhir Journal: Proc Natl Acad Sci U S A Date: 2019-05-23 Impact factor: 11.205
Authors: Jim O'Doherty; Maite Jauregui-Osoro; Teresa Brothwood; Teresa Szyszko; Paul K Marsden; Michael J O'Doherty; Gary J R Cook; Philip J Blower; Val Lewington Journal: J Nucl Med Date: 2017-04-06 Impact factor: 10.057
Authors: Giancarlo Pascali; Lidia Matesic; Bo Zhang; Andrew T King; Andrea J Robinson; Alison T Ung; Benjamin H Fraser Journal: EJNMMI Radiopharm Chem Date: 2017-07-17
Authors: Francesco M Monzittu; Imtiaz Khan; William Levason; Sajinder K Luthra; Graeme McRobbie; Gillian Reid Journal: Angew Chem Int Ed Engl Date: 2018-04-26 Impact factor: 15.336